Medikaloka Hermina Tbk PT
IDX:HEAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
ID |
|
Tryg A/S
CSE:TRYG
|
DK |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Schneider Electric SE
OTC:SBGSF
|
FR |
|
Galaxy Digital Inc
NASDAQ:GLXY
|
US |
|
Duolingo Inc
NASDAQ:DUOL
|
US |
|
National Energy Services Reunited Corp
NASDAQ:NESR
|
US |
|
Charter Hall Long WALE REIT
ASX:CLW
|
AU |
|
Ducon Infratechnologies Ltd
NSE:DUCON
|
IN |
|
Atos SE
F:AXI0
|
FR |
|
D-Box Technologies Inc
TSX:DBO
|
CA |
|
E
|
Eversendai Corporation Bhd
KLSE:SENDAI
|
MY |
|
I
|
Insulet Corp
XBER:GOV
|
US |
|
Vivendi SE
PAR:VIV
|
FR |
|
A
|
Atlas Copco AB
DUS:ACO5
|
SE |
|
Eversource Energy
NYSE:ES
|
US |
|
Cogeco Inc
TSX:CGO
|
CA |
Wall St Price Targets
HEAL Price Targets Summary
Medikaloka Hermina Tbk PT
According to Wall Street analysts, the average 1-year price target for
HEAL is 1 645.45 IDR with a low forecast of 1 161.5 IDR and a high forecast of 2 047.5 IDR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HEAL's stock price target?
Price Target
1 645.45
IDR
According to Wall Street analysts, the average 1-year price target for
HEAL is 1 645.45 IDR with a low forecast of 1 161.5 IDR and a high forecast of 2 047.5 IDR.
What is the Revenue forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
10%
Over the last 9 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
19%
Over the last 9 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 2 years is 19%.
What is the Net Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
12%
Over the last 9 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 12%.